76.6 F
New York
Thursday, July 29, 2021

Clene [NASDAQ: CLNN] Gets Two Patent Notice of Allowances

Must read

Digital Realty [NYSE: DLR] Considering Developing 64 MW Facility in South Korea

Digital Realty Trust, Inc. has shown its intention to build the 64-megawatt facility in Seoul, South Korea. The firm has decided that the...

Why Shares of IZEA Worldwide [NASDAQ: IZEA] Skyrocketing Today?

Shares of IZEA Worldwide, Inc. surged 8.10% at the time of writing on Wednesday. The strong performance of the firm has highlighted the...

BIT Mining [NYSE: BTCM] Ink Purchase Agreement to Buy Bitcoin Mining Machine

BIT Mining Limited has inked a purchase agreement to increase the fleet of bitcoin mining machines. As per the new purchase agreement, the...

Dyadic International [NASDAQ: DYAI] Inks Licensing Agreement with the Rubic Consortium

Dyadic International, Inc. disclosed that it has inked a COVID-19 vaccine technology transfer and licensing agreement with the Rubic Consortium. It has been...

Clene Inc. [NASDAQ: CLNN] disclosed that Clene Nanomedicine, Inc. U.S. Patent and Trademark Office has provided Notices of Allowance for two significant patent applications. Clene Nanomedicine is the subsidiary of CNN. Additionally, the notices include device and process entitled for its platform technology and sophisticated stage clean-surfaced nanocrystal therapeutic candidates.

The first allowed application named “Continuous Methods for Treating Liquids and Manufacturing Certain Constituents in Liquids, Apparatuses, and Nanoparticles and Nanoparticle/Liquid Solution(s) Resulting Therefrom”. It includes a vast range of device privileges related to electrochemical technology platforms for CLNN for making solutions and suspensions.

Furthermore, it has been disclosed that both patents, once granted, will continue to offer important intellectual property protection for CNM-Au8. CNM-Au8 is the top drug candidate of Clene. CNM-Au8 is now being assessed across seven clinical studies for the cure of amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Parkinson’s disease.

Additionally, the global patent portfolio in the new field of clean-surfaced nanocrystal therapeutics of Clene now covers over 130 patents. These patents are granted and allowed. Moreover, it has been disclosed that nearly 30 more applications are still waiting.

Additionally, the granted patents include state of matter claims for suspensions and solutions, as well as processes for making the materials, devices for overseeing the unique electro-crystal chemistry processes, and methods of using the novel materials.

More articles

Latest article

Binance, FTX Cut Leverage Limits on Crypto Futures Trading to 20x

Two major cryptocurrency trading platforms Binance Futures and FTX disclosed on Monday that they both have made a remarkable decision related to the crypto...

TD Holdings [NASDAQ: GLG] Inks Letter of Intent with Guangdong Jinbochuang

TD Holdings, Inc. has inked a letter of intent (LOI) with Guangdong Jinbochuang Special Purpose Vehicle Co., Ltd. and (Jinbochuang) and Hunan Jinmeike...

ASGN [NYSE: ASGN] Acquire IndraSoft Inc

ASGN Incorporated disclosed that it has acquired IndraSoft Inc. IndraSoft Inc has gained recognition as a prominent cybersecurity and digital transformation solutions offeror...

Link Reservations Decides to Accept Bitcoin/Crypto Payments

Link Reservations Inc disclosed Friday that it has decided to start accepting Bitcoin and cryptocurrency payments. This is the major breakthrough for the firm...

Athene [NYSE: ATH] Announces Acquisition of Foundation Home Loans

Athene Holding Ltd. disclosed on Thursday that it has inked a definitive agreement to purchase Foundation Home Loans (FHL). FHL had a £3...

Ping [NYSE: PING] and Anexinet Announces Partnership

Ping Identity Holding Corp. and Anexinet Corporation have both entered into a partnership agreement. The collaboration will integrate Ping Identity’s centralized Identity Access...

Digital Realty [NYSE: DLR] and Brookfield Announces Joint Venture

Digital Realty Trust, Inc.   and Brookfield Infrastructure Partners L.P. and its institutional partners disclosed on Wednesday that they have launched a 50/50 joint...

Red Cat [NASDAQ: RCAT] Announces Acquisition of Teal Drones

Red Cat Holdings, Inc. has inked an agreement on Tuesday to buy Teal Drones in an all-stock transaction. This acquisition will add Teal...